ImmuCell (NASDAQ: ICCC)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of ImmuCell (NASDAQ: ICCC) through any online brokerage.
The latest price target for ImmuCell (NASDAQ: ICCC) was reported by Aegis Capital on Monday, July 13, 2020. The analyst firm set a price target for 14.00 expecting ICCC to rise to within 12 months (a possible 70.73% upside). 0 analyst firms have reported ratings in the last year.
The stock price for ImmuCell (NASDAQ: ICCC) is $8.2 last updated Today at July 5, 2022, 2:38 PM UTC.
There are no upcoming dividends for ImmuCell.
ImmuCell’s Q2 earnings are confirmed for Thursday, August 11, 2022.
There is no upcoming split for ImmuCell.
ImmuCell is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.